Glaucoma

Manufacturer: Newton Laboratories, Inc.
Effective date: 2011-06-01
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:05:12

Label at a glance#

ProductGlaucoma

Active ingredientAconitum Napellus, Gold, Atropa Belladonna, Causticum, Cinchona Officinalis Bark, Colchicum Autumnale Bulb, Euphrasia Stricta, Gelsemium Sempervirens Root, Strychnos Nux-vomica Seed, Osmium, Phosphorus, Physostigma Venenosum Seed, Toxicodendron Pubescens Leaf, Spigelia Anthelmia

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1.800.448.7256

Websitewww.newtonlabs.net

www.newtonlabs.net

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Glaucoma Formulated for associated symptoms such as increased intraocular pressure, swelling of eyes, atrophy of optic nerve and narrow field of vision.

DOSAGE & ADMINISTRATION SECTION

Directions: Adults, take 6 pellets orally one to four times daily or as directed by a healthcare professional. Warning: Continue to monitor intraocular pressure. Uncontrolled glaucoma can result in blindness.

ACTIVE INGREDIENT SECTION

OTC - ACTIVE INGREDIENT SECTION

Aconitum nap. 15x, Aur. met. 15x, Belladonna 15x, Causticum 15x, Cinchona 15x, Colchicum 15x, Euphrasia 15x, Gelsemium 15x, Nux vom. 15x, Osmium metallicum 15x, Phosphorus 15x, Physostigma 15x, Rhus toxicodendron 15x, Spigelia anth. 15x, Euphrasia 3x.

PURPOSE SECTION

ABUSE SECTION

Formulated for associated symptoms such as increased intraocular pressure, swelling of eyes, atrophy of optic nerve and narrow field of vision.

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS? SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256

WARNINGS SECTION

Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.

PREGNANCY OR BREAST FEEDING SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55714-4581-1	2020-01-31	C162847	48780-1	9d75b9d0-b0a1-f424-e053-dadaa90a57ce	Glaucoma
55714-4581-2	2020-01-31	C162847	48780-1	9d75b9d0-b0a1-f424-e053-dadaa90a57ce	Glaucoma

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55714-4581-1	Glaucoma	28.35 g in 1 BOTTLE, GLASS	PELLET	28.35		1
55714-4581-2	Glaucoma	56.7 g in 1 BOTTLE, GLASS	PELLET	56.7		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55714-4581	GLAUCOMA (ACONITUM NAP., AUR. MET., BELLADONNA, CAUSTICUM, CINCHONA, COLCHICUM, EUPHRASIA, GELSEMIUM, NUX VOM., OSMIUM METALLICUM, PHOSPHORUS, PHYSOSTIGMA, RHUS TOXICODENDRON, SPIGELIA ANTH.) PELLET [NEWTON LABORATORIES, INC.]	1	Legacy NDC, 2 package rows	20131112_d2566f25-1d83-46eb-b136-8bc6e12f5098.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Aconitum Napellus	ACTIVE INGREDIENT	U0NQ8555JD	1
Atropa Belladonna	ACTIVE INGREDIENT	WQZ3G9PF0H	1
Causticum	ACTIVE INGREDIENT	DD5FO1WKFU	1
Cinchona Officinalis Bark	ACTIVE INGREDIENT	S003A158SB	1
Colchicum Autumnale Bulb	ACTIVE INGREDIENT	993QHL78E6	1
Euphrasia Stricta	ACTIVE INGREDIENT	C9642I91WL	1
Gelsemium Sempervirens Root	ACTIVE INGREDIENT	639KR60Q1Q	1
Gold	ACTIVE INGREDIENT	79Y1949PYO	1
Osmium	ACTIVE INGREDIENT	2E7M255OPY	1
Phosphorus	ACTIVE INGREDIENT	27YLU75U4W	1
Physostigma Venenosum Seed	ACTIVE INGREDIENT	CJV9E9IIOA	1
Spigelia Anthelmia	ACTIVE INGREDIENT	WYT05213GE	1
Strychnos Nux-vomica Seed	ACTIVE INGREDIENT	269XH13919	1
Toxicodendron Pubescens Leaf	ACTIVE INGREDIENT	6IO182RP7A	1
Aconitum Napellus	ACTIVE MOIETY	U0NQ8555JD	1
Atropa Belladonna	ACTIVE MOIETY	WQZ3G9PF0H	1
Causticum	ACTIVE MOIETY	DD5FO1WKFU	1
Cinchona Officinalis Bark	ACTIVE MOIETY	S003A158SB	1
Colchicum Autumnale Bulb	ACTIVE MOIETY	993QHL78E6	1
Euphrasia Stricta	ACTIVE MOIETY	C9642I91WL	1
Gelsemium Sempervirens Root	ACTIVE MOIETY	639KR60Q1Q	1
Gold	ACTIVE MOIETY	79Y1949PYO	1
Osmium	ACTIVE MOIETY	2E7M255OPY	1
Phosphorus	ACTIVE MOIETY	27YLU75U4W	1
Physostigma Venenosum Seed	ACTIVE MOIETY	CJV9E9IIOA	1
Spigelia Anthelmia	ACTIVE MOIETY	WYT05213GE	1
Strychnos Nux-vomica Seed	ACTIVE MOIETY	269XH13919	1
Toxicodendron Pubescens Leaf	ACTIVE MOIETY	6IO182RP7A	1
Sucrose	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

Glaucoma
Aconitum nap., Aur. met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux vom., Osmium metallicum, Phosphorus, Physostigma, Rhus toxicodendron, Spigelia anth.
Aconitum Napellus
Gold
Atropa Belladonna
Causticum
Cinchona Officinalis Bark
Colchicum Autumnale Bulb
Euphrasia Stricta
Gelsemium Sempervirens Root
Strychnos Nux-vomica Seed
Osmium
Phosphorus
Physostigma Venenosum Seed
Toxicodendron Pubescens Leaf
Spigelia Anthelmia
Sucrose

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55714-4581	55714-4581-1, 55714-4581-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Aconitum Napellus	U0NQ8555JD	ACTIB
Gold	79Y1949PYO	ACTIB
Atropa Belladonna	WQZ3G9PF0H	ACTIB
Causticum	DD5FO1WKFU	ACTIB
Cinchona Officinalis Bark	S003A158SB	ACTIB
Colchicum Autumnale Bulb	993QHL78E6	ACTIB
Euphrasia Stricta	C9642I91WL	ACTIB
Gelsemium Sempervirens Root	639KR60Q1Q	ACTIB
Strychnos Nux-vomica Seed	269XH13919	ACTIB
Osmium	2E7M255OPY	ACTIB
Phosphorus	27YLU75U4W	ACTIB
Physostigma Venenosum Seed	CJV9E9IIOA	ACTIB
Toxicodendron Pubescens Leaf	6IO182RP7A	ACTIB
Spigelia Anthelmia	WYT05213GE	ACTIB
Sucrose	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
f9b9f588-fd69-3ec2-1fd1-991ce8039491			d2566f25-1d83-46eb-b136-8bc6e12f5098	2011-06-01	Warnings	Exact identifier spl id: f9b9f588-fd69-3ec2-1fd1-991ce8039491 spl set id: d2566f25-1d83-46eb-b136-8bc6e12f5098

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.